Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page
- Check6 days agoChange DetectedThe page now includes new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and an updated Intervention/Treatment label, along with a Revision: v3.6.0 entry; the older Intervention / Treatment label and Revision: v3.5.5 entry were removed.SummaryDifference0.3%

- Check13 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page's metadata. No study data or visible content was changed.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor update to the page version.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page footer was updated to reflect a newer ClinicalTrials.gov site revision (from v3.5.2 to v3.5.3).SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded the term Gaucher disease type I as a keyword on the page to reflect the specific condition studied.SummaryDifference0.1%

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.